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Summary 
The C-C chemokines RANTES and monocyte chemotactic protein-3 (MCP-3) are potent chemoat- 
tractants in vitro for eosinophils and other cell types associated with allergic reactions. We tested 
the hypothesis that the aUergen-induced infiltration of eosinophils, T  cells,  and macrophages 
in the skin of atopic subjects is accompanied by the appearance of mRNA + cells for RANTES 
and MCP-3.  Cryostat sections were obtained from skin biopsies from six subjects 6,  24,  and 
48 h after allergen challenge. Tissue was processed for immunocytochemistry (ICC) and for in 
situ hybridization using 3SS-labeled riboprobes for RANTES and MCP-3. In contrast to diluent 
controls,  allergen provoked a significant increase in mKNA + cells for MCP-3,  which peaked 
at 6 h  and progressively declined at  24 and 48 h. This paralleled the kinetics of total (major 
basic  protein  positive  [MBP] +)  and  activated  (cleaved  form  of eosinophil  cationic  protein 
[EG2] +) eosinophil infiltration. The aUergen-induced expression of cells mRNA + for RANTES 
was also clearly demonstrable at 6 h. However, the numbers were maximal at 24 h and declined 
slightly at  the 48-h  time point.  The number of mRNA + cells  for RANTES  paralleled the 
kinetics of infiltration of CD3 +, CD4 +, and CD8 + T  cells whereas the number of CD68 § 
macrophages was still increasing at 48 h. These data support the view that MCP-3 is involved 
in the regulation of the early eosinophil response to specific allergen, whereas RANTES may 
have more relevance to the later  accumulation of T  cells and macrophages. 
T 
he allergen-induced cutaneous late phase response (LPK) 1 
is a useful model of atopic allergic inflammation (1, 2). 
By applying the techniques of immunocytochemistry (ICC) 
and in situ hybridization (ISH) to full thickness skin biopsies, 
the LPR was shown to be associated with the infiltration 
of EG2 + eosinophils, elastase + neutrophils, CD3 +, CD4 +, 
and CD8 + T  cells,  UCHL1 + (CD45RO +) memory cells, 
CD68 + macrophages, as well as cells expressing mRNA for 
the Th2-type cytokines I1:4 and II:5 (1-5). The precise mech- 
anisms for the recruitment of eosinophils, T cells, and other 
inflammatory cells into  allergen-injected sites are still un- 
known. However, present evidence suggests that this pro- 
cess involves selective cell adhesion, chemotaxis and prolonged 
survival of specific inflammatory cells consequent to the local 
release of cytokines and other mediators from IgE-sensitized 
mast cells and allergen-specific T  cells (6-8). 
1Abbreviations used in this paper: EG2, cleaved form of eosin cationic pro- 
tein; ICC, immunocytochemistry; ISH, in situ hybridization; LPK, late- 
phase response; MBP, major basic protein; MCP-3, monocyte chemotactic 
protein-3; RANTES, regulated upon activation in normal T cells expressed 
and secreted;  TEM,  transendothelial migration. 
The role of chemokines as specific chemotactic factors in 
allergic tissue reactions is of considerable current interest. 
Chemokines, also known as intercrines, comprise a super- 
family of small peptides (8-14 kD) which can be divided into 
two subfamilies, based on the arrangement of the structural 
motif containing two cysteines, either separated or adjacent 
(C-X-C chemokines and C-C chemokines, respectively) (7). 
Chemokines of the C-X-C type include I1:8 and are predom- 
inantly chemotactic in vitro for neutrophils. In contrast, C-C 
chemokines attract T  cell subsets and specific  granulocytes 
other than neutrophils (7,  9-11).  RANTES,  a member of 
the C-C  family, is chemotactic for eosinophils, basophils, 
monocyte/macrophages, and CD4 +/UCHL1 +  "memory" 
T  cells (11-13). A more recently described C-C chemokine 
is monocyte chemotactic protein-3 (MCP-3) (14).  MCP-3 is 
approximately equivalent, in term of potency, to RANTES 
in eosinophil and basophil chemotaxis (11, 15).  The effect 
of MCP-3 on T  cell locomotion has yet to be established. 
Since MCP-3 and RANTES also stimulate histamine release 
from human basophils and promote exocytosis of eosinophil 
granule proteins in vitro (11, 16, 17), they have the potential 
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these reasons, we hypothesized that exposure to a specific al- 
lergen  induces  transcription  of  mRNA  for  MCP-3  and 
RANTES in the skin of human atopic subjects and that the 
time course of appearance of mRNA + ceils is related to that 
of the accumulation of eosinophils, T  cells and macrophages. 
Materials  and Methods 
Human Subjects.  Six atopic subjects (two females and 4 males; 
mean age  =  38.5  _+ 2.8 yr old) were recruited from the Allergy 
Clinic of the Royal Brompton Hospital (London, UK) and from 
the staff of the National Heart & Lung Institute (London, UK) 
Inclusion criteria for the subjects were as follows: (a) age between 
18 and 55 yr old; (b) history of seasonal and/or perennial allergic 
rhinitis and/or asthma; (c) absence of any other illness; (d) positive 
skin prick tests  (weal diameter >5 ram) to Timothy grass pollen 
(Pkleum pratense; Soluprick; ALK, Horsholm, Denmark) or house 
dust mite extract (ALK) in the presence of positive histamine and 
negative vehicle controls. Patients taking oral medication were not 
included in the study. The total IgE levels ranged from 101 to 1,780 
IU/ml and all patients had positive RAST results to Phleum pratense 
(6.3-100 IU/ml). 
Study Design.  The study was approved by the Royal Brompton 
Hospital Ethics Committee and was performed with the patients' 
written informed consent. 30 BU of Timothy grass pollen extract 
(0.02 ml) were injected intradermally into three sites on the ex- 
tensor aspect  of the forearms of each subject.  A fourth site was 
injected with a similar volume of diluent. Macroscopic responses 
were measured at 6, 24,  and 48 h by evaluating skin induration 
by resistance  to the movement of a sharpened pencil point with 
which the reaction was outlined. Permanent sticky tape records 
of the outlines of the responses at all time points were then made. 
One site injected with allergen was biopsied at 6, 24, or 48 h, im- 
mediately after measurement of the size of the reaction. The con- 
trol site injected with diluent was biopsied at 24 h. In this way, 
each patient served as his/her own control. A 4-mm disposable 
biopsy punch was used to take biopsies after using 1% plain lido- 
caine for local anaesthesia. 
Processing of Specimens.  Tissue biopsies were immediately fixed 
in 4% paraformaldehyde (BDH Chemicals Ltd., Dagenham, UK) 
in PBS, pH 7.4, for 4 h, and washed with 15%  sucrose  (Sigma 
Chemical Co., Poole, UK) in PBS for 1 h twice, then snap frozen 
in isopentane (BDH Chemicals) cooled in liquid nitrogen. Cryostat 
sections (6/~m) were cut from biopsies, mounted on 0.1% poly-L- 
lysine-coated RNase-free slides, dried overnight at 37~  then stored 
at  - 80~ 
ICC.  The alkaline phosphatase anti-alkaline phosphatase  tech- 
nique was used to enumerate cells binding to monoclonal antibodies 
against  human T cells (CD3, Becton Dickinson, Cowley, Oxon, 
UK), helper T cells (CD4, Becton Dickinson), cytotoxic T cells 
(CD8, Becton Dickinson), total eosinophils  (BMK-13, [18]), acti- 
vated eosinophils (EG2;  Pharmacia,  Uppsala, Sweden), and mac- 
rophages (CD68, Dako, High Wycombe, U.K.).  The technique 
was performed as described previously (1-3). 
ISH.  cDNA for human RANTES and MCP-3 were kind gifts 
from Dr. P. Nelson (Department of Pediatrics,  Stanford Univer- 
sity, Stanford, CA) and Dr. G. Opdenakker (Laboratory of Molec- 
ular Medicine,  Rega Institute, University of Leuven, Belgium), 
respectively  (10, 11). Radiolabeled (3sS; Amersham International, 
Amersham, UK) riboprobes (both sense and antisense)  were pre- 
pared as before (4-5). ISH was performed as previously described 
(4-5) with some modifications. Briefly, cryostat sections were per- 
meabilized by immersion in 0.3% Triton X-100 in PBS for 10 min. 
After a brief wash in PBS, sections were further permeabilized by 
exposure to proteinase K (Promega, Southampton, UK) solution 
(1/zg/ml in 20 mM Tris-HCl and 1 mM EDTA, pH 7.2) for 30 
rain at 37~  the activity of which was then terminated by immer- 
sion in 4% paraformaldehyde/PBS  for 5 min. To inhibit nonspecific 
binding of 35S-labeled probes,  sections were treated with 10 mM 
iodoacetamide and N-ethyl-malemide (Sigma) for 30 min at 37~ 
and then 0.5% acetic anhydride and 0.1 M triethanolamine for 10 
rain before air drying. Sections  were hybridized with 3sS-labeled 
riboprobes (either antisense or sense at 106 cpm per section) in hy- 
bridization buffer containing 100 mM DTT (Promega) at 55~ 
overnight. Slides were then washed twice in 50% formamide/2 x 
SSC containing 10 mM DTT at 50~  for 20 min, incubated with 
20/zg/ml of RNase A (Sigma)  in 2 x  SSC for 30 rain at 37~ 
to remove any unhybridized RNA, and washed in 2x  SSC (65~ 
20 min) followed by 0.1x SSC (65~  20 rain). After dehydration, 
sections  were immersed in K-5 emulsion (Ilford, Basildon,  UK) 
and exposed for 14 d at 4~  The autoradiographs were developed 
in developing solution (D-19; Eastman Kodak Co., Rochester, NY), 
fixed with Hypam (Ilford), and counterstained with hematoxylin. 
For negative controls, slides were hybridized to sense probes or 
pretreated with RNase A prior to hybridization with antisense 
probes  (4,5). 
Quantitation.  For both ICC and ISH, slides were counted blind 
in a coded random order by the two observers.  Hybrids between 
chemokine mRNA and riboprobes were localized as dense collec- 
tions of silver grains  overlying individual cells. Since it was not 
possible to count individual silver grains, cells expressing chemokine- 
specific mRNA were quantified in terms of the numbers of cells 
with overlying silver grains. When positive cells were in close prox- 
imity, their numbers were determined by visualizing individual 
nuclei using dark-field illumination.  Positive cells were counted with 
an eyepiece graticule at a magnification of 200.  For each biopsy, 
at least two sections were stained for each antibody (ICC) or hy- 
bridized with each riboprobe (ISH), from which four to six fields 
were counted. Results are expressed as the numbers of positive cells 
per field (0.202 mm2). The mean coefficient of variation of the cell 
counts did not exceed 5%. 
Analysis.  Data were analyzed using a statistical package (Minitab 
Release 7, Minitab Inc., State College, PA). Comparisons within 
the different time points for each cellular marker or each antisense 
riboprobe were performed by Friedman's test. For all tests, P <0.05 
was considered significant. 
Results 
All subjects exhibited cutaneous  LPR after allergen but 
not  diluent  control  challenge  (P  <0.02).  The  mean  size 
(ram  _+ SEM) of the LPR was 75.7  _+  10.5 (6h), 71.8  _+ 15.3 
(24 h),  and  68.5  _  16.5  (48 h). 
Using  Friedman's  test,  which compares diluent with  all 
three allergen-challenged time points (i.e. 6, 24, and 48 h), 
there were significant increases in the numbers of CD3 + (P 
=  0.002), CD4 + (P  -  0.004), CD8 + (P =  0.014) T  cells, 
eosinophils (MBP + and EG2 +, P <0.001), and CD68 + mac- 
rophages  (P  =  0.004).  The  mean  numbers  of  CD3 +, 
CD4 +, and CD8 + cells were maximal at 24 h after allergen 
challenge and subsequently declined, although they remained 
elevated compared to those in diluent-challenged sites up to 
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6 h time point, then declined at 24 h and at 48 h, although 
they were still elevated at these time points when compared 
to those in diluent-challenged sites. The numbers of CD68 + 
macrophages  infiltrating  the allergen-challenged  sites  con- 
tinued  to be elevated for up to 48 h  after challenge. 
Friedman's test also showed significantly increased numbers 
of cells  expressing  chemokine  mRNA  for  RANTES  and 
MCP-3  (P  =  0.005  and 0.003,  respectively; Fig.  1).  The 
numbers  of cells expressing R.ANTES mRNA  were max- 
imal at 24 h  after allergen challenge,  whereas the peak ex- 
pression for MCP-3 was at 6 h.  No significant correlation 
between the number of cells expressing MCP-3 or R.ANTES 
and the number of infiltrating  inflammatory  cells was ob- 
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Figure  1.  Time  course of appearance of mRNA § cells for MCP-3 and 
RANTES, eosinophils (MBP  + and EG2 + cells), T cells (CD3 +, CD4 + 
and CD8 +) and macrophages (CD68  +) into allergen-challenged skin sites 
in atopic subjects (n  =  6). Diluent-challenged sites (Dil) were used as 
controls. The results are expressed as the numbers of positive cells (mean 
_+ SEM) per field (0.202 mm 2) of skin biopsies. Significant differences 
(diluent, 6-, 24-, and 48-h allergen-challenge time points, Friedman's test) 
were for MCP-3 (P = 0.003), tLANTES (P =  0.005), MBP and EG2 
(P <0.001), CD3 (P = 0.002), CD68 and CD4 (P = 0.004) and CD8 
(1, =  o.o~4). 
served. At diluent-challenged  sites,  very occasional hybrid- 
ization signals were observed for R.ANTES and MCP-3. No 
hybridization signals were observed in the sections pretreated 
with RNase A or the sections treated with the sense probes 
(Fig. 2). These observations further confirm that the hybrid- 
ization  signals  observed represent  specific  binding  and be- 
tween target  mRNA  and antisense  riboprobes. 
Chemokine mRNA-positive cells were generally located 
within areas of inflammatory infiltrate at the upper part of 
the dermis  as well as in the deep reticular dermis  (Fig.  2). 
Discussion 
The novelty of this study is (a) the demonstration of MCP-3 
and RANTES mRNA-positive cells in human tissue and (b) 
their induction by specific antigen in sensitized atopic sub- 
jects. Furthermore, we observed an early peak (6 h) in MCP-3 
and a later peak (24 h)  in RANTES mRNA-positive cell 
numbers. Although there were no significant correlations be- 
tween the numbers of chemokine mRNA-positive cells and 
the various specific cell types, the time courses of the expres- 
sion of mRNA encoding MCP-3 and RANTES were similar 
to the time courses of accumulation of eosinophils and T cells, 
respectively. While these observations give no definite infor- 
mation as to the cellular source of the chemokine mRNA, 
they are compatible with the hypotheses that  MCP-3  and 
P.ANTES are important in eosinophil and T cell recruitment 
(11-16),  or  that  these  cells  are  a  possible source  of these 
chemokines. 
CC chemokines  such as MCP-3  and R.ANTES may act 
in concert with other cytokines, such as IL-4 and IL-5, which 
are also implicated in recruiting eosinophils into sites of al- 
lergic inflammation  (6,  7,  11). For example, Ebisawa et al. 
showed that  RANTES was an effective inducer of eosino- 
phil transendothelial  migration (TEM) in vitro, and that preex- 
posure of eosinophils to IL-5 substantially potentiated the TEM 
response  to  P.ANTES  (19).  Furthermore,  when  human 
RANTES was injected into the skin of dogs,  this induced 
local accumulation of eosinophils, monocytes, and lympho- 
cytes, which was maximal  at  16-24  h  after injection (20). 
All these observations indicate that  MCP-3 and RANTES 
may play an important role in local eosinophil recruitment. 
It  was  previously  demonstrated  that  the  majority  of 
CD4 + T cells infiltrating the sites of allergen-induced cuta- 
neous LPR were of the "memory" (CD45RO +) phenotype 
(3). The present findings are consistent with a role for locally 
released RANTES in recruiting cells of this phenotype (13). 
The cell type(s) responsible for positive hybridization signals 
for R.ANTES and MCP-3 will be the subject of further studies. 
However, it is known  that  MCP-3  is mainly produced by 
monocytes (7), whereas many cell types synthesize RANTES. 
These include T  cells,  epithelial cells,  platelets,  fibroblasts, 
macrophages, and endothelial cells (12, 21-23). It is also pos- 
sible that the cell types expressing RANTES may differ (a) 
in various types of inflammation and (b) during the time course 
of a specific allergic inflammatory response such as the allergen- 
induced LPR. 
2155  Ying et al. 2156  MCP-3  and RANTES mRNA in the Skin of Atopic Subjects Figure  2.  (A-H) Serial cryostat sections of a representative  skin biopsy from an atopic subject 24 h after allergen challenge and diluent challenge. 
(A) In situ hybridization with ~sS-labeled  antisense riboprobe for RANTES. Several  RANTES mRNA + cells are observed (le~, arrowed). The same 
section shown in dark field (rght). (B) mRNA + cells for MCP-3 from the same biopsy (bright and dark field). Note that fewer cells were mRNA- 
positive for MCP-3 than for KANTES 24 h after allergen  challenge. No positive hybridization signals were observed  when the sections were hybridized 
with asS-labeled sense riboprobes for RANTES (C, bright and dark field) or MCP-3 (D, bright  and dark field). No positive signals were found in 
the diluent challenge sites by use of 3sS-labeled antisense riboprobes for RANTES (E, bright and dark field) or MCP-3 (F, bright  and dark field). 
(G and H) The infiltration of CD4 + T cells and EG2 + eosinophils, respectively, 6 h after allergen challenge. 
As previously stated, RANTES and MCPo3 have also been 
found to be chemotactic for basophils  (11,  15).  However, a 
specific phenotypic marker for this cell type is not currently 
available for immunocytochemical studies. At the present time, 
there is no evidence that C-C chemokines enhance the sur- 
vival of eosinophils  and basophils  in vitro.  It is,  therefore, 
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reasonable to hypothesize that C-C chemokines play a role 
in TEM ofT cells, basophils, and eosinophils, whereas TH2- 
type cytokines (e.g., IL-3, IL-4, IL-5, and GM-CSF) (4, 5,  8) 
cooperate with CC chemokines to prime,  activate, and en- 
hance survival of these cell types.  Thus,  all  these elements 
have the potential to amplify atopic allergic reactions in humans (11). Therefore, the inhibition of C-C chemokines and Th2- 
type cytokines may have therapeutic relevance in the treat- 
ment of atopic disease. 
In conclusion, the demonstration of increased numbers of 
cells expressing  C-C chemokine mRNA for RANTES and 
MCP-3 with different kinetics suggests that these chemokines 
may participate in the recruitment of inflammatory cells in 
atopic allergic  inflammation. 
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